US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

66.97

-0.3971-0.59%

Post-market: 66.87-0.1033-0.15%16:10 EDT

Volume:322

Turnover:21.54K

Market Cap:669.80K

PE:- -

High:66.97

Open:66.92

Low:66.87

Close:67.37

52wk High:85.03

52wk Low:60.91

Shares:10.00K

Float Shares:10.00K

Volume Ratio:1.48

T/O Rate:3.22%

Dividend:2.08

Dividend Rate:3.10%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients

Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS

Guggenheim Remains a Hold on GlaxoSmithKline (GSK)

GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China

Revenue Revision at Frontier Biotech Highlights Channel Pressures as Operating Losses Widen

GSK US President Acquires Notional ADS Under Executive Savings Plan

GSK Adds Philips CEO Roy Jakobs to Board as Independent Director

SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE

Alector Ends GSK Collaboration, Retires Hercules Capital Debt

GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio

GSK Targets Pediatric Vaccine Growth With New Phase 3 Trial Against Merck’s ProQuad

GSK Advances Novel Malaria Drug Into Phase 2A, Signaling Long-Term Global Health Upside

GSK Advances New Malaria Drug With Completed First-in-Human Study

Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...

GSK, Sino Biopharmaceutical Unit Expand Collaboration to Cover Two GSK Respiratory Therapies

MT Newswires Live

Barclays Remains a Sell on GlaxoSmithKline (GSK)

Dow Jones Top Company Headlines at 3 am ET: Sino Biopharm Strikes Drug Licensing Deal with Astrazeneca, Deepens GSK Partnership | White ...

Sino Biopharm Deepens GSK Respiratory Deal to Cement China Lead

GSK’s StrateGIST Frontline Trial Puts New Cancer Drug Velzatinib in the Spotlight

HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/GSKH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":66.9733,"timestamp":1790971200000,"preClose":67.3704,"halted":0,"volume":322,"hourTrading":{"tag":"盘后","latestPrice":66.87,"preClose":66.9733,"latestTime":"16:10 EDT","volume":6,"amount":401.8398,"timestamp":1790971804755,"change":-0.1033,"changeRate":-0.001542,"amplitude":0},"delay":0,"changeRate":-0.005894279980525704,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Closed","change":-0.3971,"latestTime":"10-02 16:00:00 EDT","open":66.92,"high":66.9733,"low":66.87,"amount":21541,"amplitude":0.001533,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":67.3704,"nav":67.293936,"aum":673006.653936,"dividendRate":0.031027,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":66.87,"preClose":66.9733,"latestTime":"16:10 EDT","volume":6,"amount":401.8398,"timestamp":1790971804755,"change":-0.1033,"changeRate":-0.001542,"amplitude":0},"volumeRatio":1.477065,"impliedVol":0.226,"impliedVolPercentile":0.7734},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.477065,"shares":10001,"dividePrice":2.078,"high":66.9733,"amplitude":0.001533,"preClose":67.3704,"low":66.87,"week52Low":60.91,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":66.9733,"eps":0,"divideRate":0.031027,"volume":322,"delay":0,"ttmEps":0,"open":66.92,"prevYearClose":68.2031,"prevWeekClose":70.0101,"prevMonthClose":68.5811,"prevQuarterClose":68.5811,"fiveDayClose":70.0101,"twentyDayClose":70.7456,"sixtyDayClose":73.1482},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651954591","title":"GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2651954591","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651954591?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:09","pubTimestamp":1783922982,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has reported positive interim phase II AZUR-1 data for its PD‑1 inhibitor Jemperli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-jemperli-trial-points-to-chemofree-future-for-subset-of-rectal-cancer-patients?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-jemperli-trial-points-to-chemofree-future-for-subset-of-rectal-cancer-patients?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4588","PCOM","GSK","BK4007","BK4585","BK4122","GSKH","GSK.UK","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156997423","title":"Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS","url":"https://stock-news.laohu8.com/highlight/detail?id=1156997423","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156997423?lang=en_us&edition=fundamental","pubTime":"2026-07-13 10:10","pubTimestamp":1783908642,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) shares rose more than 7% in early trading. At the time of writing, the stock is up 6.21% to HK$45.48, with a turnover of HK$332 million. On July 13th, according to a post on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYV24P56.USD","IBB","SBIO","LU2488822045.USD","IE00BVYPNP33.GBP","GDOC","CHAT","QTOC","SG9999004220.SGD","SG9999015945.SGD","VTHR","IE00BGHQDM52.EUR","SG9999015952.SGD","SG9999015986.USD","AIPO","WRND","IE00BMCWC346.EUR","BK4585","00867","BBP","ARTY","SG9999015978.USD","BK4588","AGIX","LFSC","IE00BVYPNQ40.USD","BK1593","PBE","GSKH","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650139214","title":"Guggenheim Remains a Hold on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650139214","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650139214?lang=en_us&edition=fundamental","pubTime":"2026-07-10 23:45","pubTimestamp":1783698318,"startTime":"0","endTime":"0","summary":"Guggenheim analyst maintained a Hold rating on GlaxoSmithKline yesterday. The company’s shares closed today at p1,959.50. In addition to Guggenheim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","LU1829250122.USD","BK4585","BK4532","BK4007","GSKH","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650182181","title":"GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2650182181","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650182181?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:10","pubTimestamp":1783681857,"startTime":"0","endTime":"0","summary":"GSK (GSK) plc licensor Hansoh Pharmaceutical Group announced that ARTEMIS-008, its pivotal phase III trial evaluating risvutatug rezetecan, or Ris-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-says-hansoh-pharma-announces-positive-phase-3-results-for-ris-rez-in-china-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-says-hansoh-pharma-announces-positive-phase-3-results-for-ris-rez-in-china-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4588","GSKH","BK4585","BK4532","GSK.UK","LU1829250122.USD","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121894437","title":"Revenue Revision at Frontier Biotech Highlights Channel Pressures as Operating Losses Widen","url":"https://stock-news.laohu8.com/highlight/detail?id=1121894437","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121894437?lang=en_us&edition=fundamental","pubTime":"2026-07-10 14:21","pubTimestamp":1783664489,"startTime":"0","endTime":"0","summary":"Frontier Biotech has responded to the Shanghai Stock Exchange's 2025 annual report inquiry letter, providing clarifications on issues including revenue recognition adjustments, distributor inventory,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4532","BK4588","SPHQ","LU1829250122.USD","GSK","GSK.UK","BK4007","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650978583","title":"GSK US President Acquires Notional ADS Under Executive Savings Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2650978583","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650978583?lang=en_us&edition=fundamental","pubTime":"2026-07-09 22:32","pubTimestamp":1783607547,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK disclosed that Maya Martinez-Davis, President of US operations and a person discharging m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-acquires-notional-ads-under-executive-savings-plan-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-us-president-acquires-notional-ads-under-executive-savings-plan-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","LU1829250122.USD","BK4588","GSK","BK4007","GSK.UK","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650940152","title":"GSK Adds Philips CEO Roy Jakobs to Board as Independent Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2650940152","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650940152?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:02","pubTimestamp":1783587750,"startTime":"0","endTime":"0","summary":"The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has appointed Roy Jakobs, the current chief executive of health technology g...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-adds-philips-ceo-roy-jakobs-to-board-as-independent-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-adds-philips-ceo-roy-jakobs-to-board-as-independent-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EKG","LU1829250122.USD","BK4585","BK4532","BK4007","GSKH","GSK","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115056703","title":"SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE","url":"https://stock-news.laohu8.com/highlight/detail?id=1115056703","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115056703?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:21","pubTimestamp":1783563660,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) climbed more than 5% during the morning session. At the time of writing, the stock was up 5.39% to HK$5.08, with a turnover of HK$239 million. Expanding a Strategic...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00BZ08YT58.USD","LU1829250122.USD","BK1521","BK4007","BK4532","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK4585","BK4588","GSK","BK1191","01177","GSK.UK","HK0000165453.HKD","BK1515","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650291696","title":"Alector Ends GSK Collaboration, Retires Hercules Capital Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2650291696","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650291696?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:32","pubTimestamp":1783542774,"startTime":"0","endTime":"0","summary":"Alector ( ($ALEC) ) has provided an announcement. On October 21, 2025, Alector reported that its Phase 3 INFRONT-3 trial of latozinemab in frontote...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alector-ends-gsk-collaboration-retires-hercules-capital-debt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alector-ends-gsk-collaboration-retires-hercules-capital-debt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","BIZD","GSKH","PBDC","BK4588","BK4585","GSK","GSK.UK","BK4007","HTGC","FXED","PEX","BK4532","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650861990","title":"GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2650861990","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650861990?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:32","pubTimestamp":1783528353,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK steps up its respiratory vaccine push with a new study, NCT07628049...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-rsv-hmpv-vaccine-trial-adds-momentum-to-its-respiratory-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-rsv-hmpv-vaccine-trial-adds-momentum-to-its-respiratory-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GSKH","GSK","LU1829250122.USD","GSK.UK","BK4585","BK4532","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650997074","title":"GSK Targets Pediatric Vaccine Growth With New Phase 3 Trial Against Merck’s ProQuad","url":"https://stock-news.laohu8.com/highlight/detail?id=2650997074","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650997074?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:32","pubTimestamp":1783528329,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running a Phase 3 study called “A Phase 3a, Observer...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-targets-pediatric-vaccine-growth-with-new-phase-3-trial-against-mercks-proquad?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-targets-pediatric-vaccine-growth-with-new-phase-3-trial-against-mercks-proquad?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGXZ57979304.SGD","BK4550","LU1989772923.USD","SG9999001176.SGD","LU1291159041.SGD","RXL","LU1162221912.USD","LU1941712264.USD","LU1066051811.HKD","LU2324357040.USD","LU2357627491.SGD","LU1093756325.SGD","LU0265550359.USD","LU2361044865.SGD","BK4588","XLV","LU0985320562.USD","BK4516","BK4532","GSKH","PPH","LU2360032135.SGD","IE0002141913.USD","SG9999014567.USD","FTXH","LU2491049909.HKD","LU0965509101.SGD","LU1069347547.HKD","VHT","IE0009355771.USD","LU2023250504.SGD","BK4585","SG9999013999.USD","GDOC","LU0058720904.USD","IE00BLSP4452.SGD","BK4534","LU1057294990.SGD","LU1585245621.USD","LU1061106388.HKD","SG9999014542.SGD","SG9999014575.USD","BK4559","LU2491050154.USD","LU2361045086.USD","LU0234572021.USD","LU1116320901.HKD","LU1829250122.USD","LU0861579265.USD","LU0106261372.USD","LU0070302665.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU0208291251.USD","LU2433249047.HKD","SG9999014559.SGD","GSK","IE00BFTCPJ56.SGD","LU0266013472.USD","LU2125909247.SGD","BK4533","LU1035773651.USD","LU1093756168.USD","HRTS","LU0320765646.SGD","LU0238689110.USD","LU1934455194.USD","LU1201861249.SGD","LU1430594728.SGD","SG9999001440.SGD","LU2468319806.SGD","LU0320765489.SGD","MRK","IE000M9KFDE8.USD","LU0289739699.SGD","LU0211331839.USD","LU1923622614.USD","LU1974910355.USD","LU0859254822.USD","LU0965508806.USD","LU1917777945.USD","LU0265550946.USD","IXJ","LU1934455277.USD","SG9999001176.USD","LU2125909593.SGD","LU2125154935.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0648001328.SGD","SG9999015341.SGD","LU0432979614.USD","LU0942090050.USD","IE00B2B36J28.USD","LU0130102774.USD","LU2125154778.USD","GSK.UK","LU2023250843.SGD","IE00B1BXHZ80.USD","LU0980610538.SGD","LU2112291526.USD","LU0098860793.USD","LU1037948897.HKD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1941712348.USD","PAWZ","LU0122379950.USD","IE00BBT3K403.USD","SG9999002232.USD","JDOC","LU2106854487.HKD","LU2089984988.USD","LU1934455863.HKD","LU1989771016.USD","LU2461242641.AUD","SG9999015358.SGD","BMED","LU0006306889.USD","LU0868494708.USD","SG9999002224.SGD","IYH","LU1066053197.SGD","LU1989772840.SGD","LU1037948541.HKD","LU0965509283.SGD","IE00BLSP4239.USD","LU0868494617.USD","IHE","LU1929549753.HKD","BK4007","IE00BN8TJ469.HKD","LU1066051225.USD","LU2491050071.SGD","LU0130517989.USD","FHLC","LU1023059063.AUD","LU0965509010.AUD","LU1983299246.USD","LU0203345920.USD","LU1699723380.USD","LU0477156953.USD","LU2361044949.HKD","LU1066051498.USD","LU1116320737.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650499086","title":"GSK Advances Novel Malaria Drug Into Phase 2A, Signaling Long-Term Global Health Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2650499086","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650499086?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:31","pubTimestamp":1783528313,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is launching a Phase 2A study called “A Phase 2A Study ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-novel-malaria-drug-into-phase-2a-signaling-long-term-global-health-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-novel-malaria-drug-into-phase-2a-signaling-long-term-global-health-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4585","LU1829250122.USD","GSKH","BK4588","GSK.UK","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650990883","title":"GSK Advances New Malaria Drug With Completed First-in-Human Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2650990883","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650990883?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:30","pubTimestamp":1783528209,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The study, officially titled A Phase 1, Randomised, Double Blind Placeb...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-malaria-drug-with-completed-first-in-human-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-malaria-drug-with-completed-first-in-human-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","LU1829250122.USD","GSK","BK4007","BK4532","GSKH","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649856998","title":"Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2649856998","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649856998?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:00","pubTimestamp":1783508400,"startTime":"0","endTime":"0","summary":"Apple to Spend $30 Billion on U.S.-Made Chips From BroadcomThe deal, for billions of chips, is the latest part of Apple's domestic investment pledge.----Trump-Backed Company Behind Family Crypto Wealt","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1951198990.SGD","LU2360032135.SGD","IE0009356076.USD","LU0234570918.USD","LU1551013425.SGD","LU1066051498.USD","AVGG","LU0354030511.USD","LU2092937148.SGD","LU0053666078.USD","LU1674673428.USD","LU0061474960.USD","LU0210528500.USD","BK4571","LU2213496289.HKD","LU2452424414.USD","LU2403377893.USD","IE00B775SV38.USD","LU0203201768.USD","LU2023250504.SGD","IE000ITXATA3.USD","BK4559","LU0234572021.USD","BK4585","LU1582986433.USD","LU1989772923.USD","LU2210150020.SGD","SG9999018865.SGD","LU1116320901.HKD","IE0004091025.USD","SG9999003800.SGD","LU0708995401.HKD","LU1923622614.USD","IE00B1XK9C88.USD","LU1868836757.USD","CGGO","LU2065171402.SGD","SG9999004220.SGD","IE00B19Z9P08.USD","LU0348723411.USD","LU1935042488.USD","LU0965509010.AUD","USXF","LU0251132253.USD","LU0056508442.USD","LU1261432733.SGD","AVGO","LU0795875086.SGD","AVS","LU1226287792.SGD","BK4566","HK0000306701.USD","LU0143551892.USD","BK4573","LU2237957811.SGD","LU2458330243.SGD","LU2272731600.USD","LU1267930573.SGD","IE000YTNTUN2.SGD","LU1291159041.SGD","LU0315179316.USD","BK4096","LU0109394709.USD","IE00BMPRXN33.USD","IE00BBT3K403.USD","LU1670628061.USD","LU0882574139.USD","LU1202635105.USD","LU0133085943.USD","LU1934455194.USD","LU2092627202.USD","AAPY","LU2211814178.USD","KURE","LU0048584097.USD","LU2505996509.AUD","BK4574","IE00BKDWB100.SGD","AAPX","LU2039709279.SGD","SHOC","LU0477156953.USD","ROM","FAI","IE000WAW04H5.SGD","RTH","LU0130102774.USD","LU0310800379.SGD","IE00BDGV0183.EUR","LU2054465674.USD","LU2764263039.SGD","LU1206713676.USD","AAPB","LU0823434740.USD","LU2125909593.SGD","LU0979878070.USD","LU0648000940.SGD","LU1127390331.HKD","LU2089984988.USD","LU0072462426.USD","LU0127658192.USD","LU0868494617.USD","LU1935042215.USD","LU1496350171.SGD","LU1989764748.USD","SG9999001440.SGD","BK4527","LU1066051811.HKD","LU2750360997.AUD","LU0312595415.SGD","IE00B4JS1V06.HKD","LU2552382132.HKD","AAPW","LU2347655156.SGD","LU2473716301.USD","LU2931357623.SGD","IE0034235295.USD","LU1992135399.USD","LU0553294199.USD","DJTWW","AAPL","LU1923623000.USD","LU0302445910.USD","LU0106261372.USD","LU2083900584.USD","LU1400636657.SGD","LU1712237335.SGD","LU0823421416.USD","LU1548497426.USD","AVGW","LU0079474960.USD","METV","LU2023251221.USD","LU2111349929.HKD","IE00B5949003.HKD","LU2360108059.USD","HK0000306685.HKD","BK4532","BK4505","ARTY","LU0823417653.USD","LU0082616367.USD","IE00BN29S564.USD","LU1226287529.USD","LU1064131342.USD","LU2077746001.SGD","LU2063271972.USD","IE00B3T34201.USD","LU2108987350.USD","IXN","LU0274383776.USD","BK4501","IE000SO60NU8.SGD","GSKH","LU0203347892.USD","NULC","BK4507","LU2430703095.HKD","LU0326950275.SGD","LU2896262040.SGD","KR","LU1316542783.SGD","LU2242650005.HKD","LU2430703251.USD","LU2125154778.USD","LU0724617625.USD","IE00B19Z9Z06.USD","LU0823421333.USD","LU2360107325.USD","LU0128525929.USD","LU1674673691.USD","LU1989764664.SGD","LU1037948541.HKD","LU0784383803.USD","UGE","LU0289960550.SGD","LU1803068979.SGD","WMTI","LU0672654240.SGD","LU2047632596.USD","LU0949170772.SGD","LU0868494708.USD","LU2279689827.SGD","LU2168563687.JPY","GM","IE00BN8TJ469.HKD","LU0149725797.USD","LU1496350502.SGD","IE000M9KFDE8.USD","LU0130517989.USD","LU1328277881.USD","AAPD","IE00BLSP4239.USD","LU2505996681.GBP","LU2420271590.USD","LU2097829019.USD","HK0000914686.HKD","LU0256863811.USD","SJM","LU2720916845.USD","IE0008368742.USD","LU0708994859.HKD","LU0323591593.USD","LU2506952170.USD","LU0689472784.USD","LU0965509101.SGD","LU1823568750.SGD","LU1642822529.SGD","LU2487616109.SGD","LU0109392836.USD","LU0080751232.USD","LU0077335932.USD","LU0345769631.USD","SGXZ23171101.USD","BK1191","LU2264538146.SGD","LU2089985449.USD","LU1852331112.SGD","LU0210536198.USD","BAI","LU0289739699.SGD","LU0109391861.USD","LU0949170426.SGD","LU3102509885.SGD","SGXZ99366536.SGD","LU0057025933.USD","LU0081259029.USD","LU1323610961.USD","TDIV","LU0985320562.USD","LU1815333072.USD","LU0096364046.USD","LU0345769128.USD","LU2764262908.HKD","LU1629891620.HKD","LU0557290698.USD","LU0820561818.USD","LU1206712785.SGD","LU2125909247.SGD","LU1951200564.SGD","TYLG","IE00BWXC8680.SGD","LU2265009873.SGD","LU0320765992.SGD","IE00B031HY20.USD","LU0889565916.HKD","BK4554","IETC","LU2347655073.USD","LU2462591350.SGD","IE00BQXX3F31.USD","BK4099","LU0061474705.USD","LU0957808578.USD","SG9999015986.USD","LU2462157665.USD","LU0061475181.USD","IE00B19Z9505.USD","AAPU","AVGX","LU0072461881.USD","IE00B3PB1722.GBP","IE00BDRTCR15.USD","LU1732800096.USD","LU0140636845.USD","LU0187121727.USD","LU2237443549.SGD","LU2468319806.SGD","LU2272731865.HKD","LU2237957902.USD","LU0211331839.USD","ABFL","LU0345768153.USD","AIFD","LU2097344357.USD","LU0965509283.SGD","SG9999014898.SGD","LU2237443895.HKD","IE00BDCRKT87.USD","TTEQ","LU1582986359.USD","LU0316494557.USD","LU0354030438.USD","IE00B894F039.SGD","LU1035773651.USD","IE000F7OJYX1.SGD","LU2133065610.SGD","BK4576","LU0011850046.USD","LU0640476718.USD","LU2237443382.USD","BK4555","SG9999014914.USD","LU2097344431.USD","LU1003077747.HKD","LU2361044949.HKD","LU0320765646.SGD","LU2168564222.USD","BK4543","LU0528227936.USD","IE00BYV24P56.USD","CHAT","LU0124676726.USD","IE00BVYPNV92.GBP","LU1720051017.SGD","LU0211327993.USD","LU2471134879.HKD","IE00BGHQF631.EUR","BK4155","LU2095319765.USD","IE00BFSS7M15.SGD","LU1506573853.SGD","LU0494093205.USD","LU1989763690.USD","LU0006061336.USD","LU2236285917.USD","LU1226288170.HKD","LU0175139822.USD","LU0289961442.SGD","IE0008369823.USD","LU2637965513.SGD","LU0211328371.USD","LU0067412154.USD","LU0417517546.SGD","LU2250418816.HKD","SG9999014575.USD","IE00BGHQDM52.EUR","IE00BSNM7G36.USD","LU1400636574.HKD","LU0511384066.AUD","LU0889565833.HKD","LU2471134796.USD","BK4588","IE0004445239.USD","GSK.UK","LU1235294995.USD","BK4550","LU2298321311.HKD","IE000MB6IJN5.SGD","IE00B775H168.HKD","LU1582987324.SGD","LU2322448791.USD","LU0980610538.SGD","MACW.SI","LU0265550946.USD","LU2087625088.SGD","LU2210149790.SGD","SMHX","LU2999663052.SGD","LU2506952097.USD","LU2954938101.SGD","ACI","IE00BZ1G4Q59.USD","LU1813983027.USD","LU1623119135.USD","LU0266013472.USD","LU0029864427.USD","LU1201861249.SGD","LU2275660780.HKD","IE0004445015.USD","IE00BZ08YS42.EUR","IE000W1ABFV2.USD","SG9999011175.SGD","LU0265550359.USD","BK4592","IE00BQXX3C00.GBP","LU1803068623.USD","SG9999018857.SGD","LU2237443465.HKD","LU2168564065.EUR","IE0001KFT4U8.USD","LU1670711040.USD","LU0820561909.HKD","LU1226288253.USD","LU2028103732.USD","BK4212","LU0310799852.SGD","LU1670710661.SGD","LU2092937221.SGD","LU2211815571.USD","LU0276348264.USD","LU0289739343.SGD","LU0786609619.USD","SG9999017495.SGD","LU0964807845.USD","LU1791710400.SGD","IE00BJJMRX11.SGD","LU1152091754.HKD","LU0943347566.SGD","LU1116320737.USD","LU0130518102.USD","IE0000B7K699.USD","LU0965508806.USD","BK4597","LU1119994496.HKD","LU0912757837.SGD","IE00BJLML261.HKD","LU2087621335.USD","LU1718418525.SGD","LU1934455277.USD","LU1992135472.HKD","SG9999014880.SGD","LU2433249047.HKD","LU2168564495.EUR","BK4515","LU1935043023.USD","LU2041044095.USD","LU2746668974.SGD","IE0034235303.USD","LU0726765562.USD","LU0444971666.USD","LU1162221912.USD","LU0069063385.USD","LU0320765489.SGD","LU0477156797.USD","BK4598","LU1035775433.USD","IE00BVYPNQ40.USD","IE00BMPRXR70.SGD","LU1046421795.USD","LU1691799644.USD","SG9999000418.SGD","LU0784384876.USD","LU1400636491.USD","LU1732799900.SGD","LU1280957306.USD","LU0070302665.USD","LU0203345920.USD","LU2237443622.USD","BK4113","BK4534","LU0719512351.SGD","SG9999001424.SGD","LU0094547139.USD","LU2592432038.USD","IE00BMPRXQ63.HKD","LU0861579265.USD","LU1084165304.USD","SPTE","LU1699723380.USD","LU1934455863.HKD","SGXZ51526630.SGD","SOXX","SG9999002232.USD","IE000BZT7R73.USD","LU1366192091.USD","LU0157215616.USD","LU0942090050.USD","LU1807302812.USD","LU0215105999.USD","01093","BK4596","LU1551013342.USD","LU0345770308.USD","LU1244550494.USD","IE00BJTD4V19.USD","LU2750360641.GBP","LU1815336760.USD","LU2361045086.USD","IE0005OL40V9.USD","LU1585245621.USD","LU1839511570.USD","LU0256863902.USD","LU0320765059.SGD","LU1242518857.USD","USD","LU1066051225.USD","SG9999014542.SGD","IE00BKPKM429.USD","IE00B42XCP33.USD","LU2023250330.USD","LU2168564149.EUR","LU0545039389.USD","LU0456855351.SGD","LU0880133367.SGD","LU1778281490.HKD","LU0738911758.USD","IE00B19Z8X17.USD","LU0162691827.USD","LU1829250122.USD","AZN","LU2357305700.SGD","LU2471134952.CNY","SG9999015358.SGD","LU2322448957.HKD","LU2461242641.AUD","LU2381873111.SGD","LU2756315318.SGD","IE00B4YYXB79.USD","LU0058720904.USD","LU0210533765.USD","LU1244550221.USD","SOXQ","TRFK","LU2430703178.SGD","BK1521","LU1989772840.SGD","IE00B3SWFQ91.USD","LU0661504455.SGD","LU0314104364.USD","LU0444973449.USD","SGXZ81514606.USD","SG9999015341.SGD","LU0683600562.USD","VGT","JGRO","BK4170","LU0170899867.USD","IE00B19Z8W00.USD","LU1670756490.USD","IE00B1BXHZ80.USD","WMT","IE00BQXX3D17.EUR","LU1935042991.SGD","LU1868837300.USD","SG9999014906.USD","LU0072913022.USD","LU0006306889.USD","LU0795875169.SGD","IE00BK4W5L77.USD","BK4553","LU2271345857.HKD","LU2456880835.USD","SG9999014567.USD","VT","LU0308772762.SGD","LU1804176565.USD","LU0198837287.USD","IE00B5MMRT66.SGD","IE0009G5SDU7.USD","SGXZ31699556.SGD","LU1868836914.USD","LU1232071149.USD","LU1037948897.HKD","AZNH","LU2506951875.HKD","IE00BVYPNP33.GBP","IE00BYXW3230.USD","LU1267930730.SGD","LU1670627923.USD","LU1993786604.SGD","LU0174119429.USD","LU0648001328.SGD","LU0788109477.HKD","LU1720051108.HKD","LU1153585028.USD","GSK","BK4504","SG9999004303.SGD","LU2065170008.USD","LU0689626769.HKD","IE00B7KXQ091.USD","SG9999015945.SGD","LU2417539215.USD","LU0353189763.USD","LU0476273544.USD","LU1226287875.USD","LU0472753341.HKD","IE00BFSS8Q28.SGD","LU0787776722.HKD","IE0034235188.USD","LU1571399168.USD","LU2023250843.SGD","IE0004086264.USD","FTEC","HK0000165453.HKD","LU2272731782.SGD","LU0950375773.USD","HK0000320264.USD","LU0957791311.USD","LU0432979614.USD","HK0000320223.HKD","TEK","LU2463028550.USD","LU1868836591.USD","LU1861219969.SGD","LU1242518931.SGD","LU1670710588.SGD","LU1244550577.SGD","IE00B3S45H60.SGD","LU1974910355.USD","IE00BVYPNW00.USD","LU0203202063.USD","IE00BJJMRY28.SGD","LU2458330169.SGD","LU2360106780.USD","BK4581","BK4516","LU2065169927.USD","LU2361044865.SGD","LU1951186391.HKD","LU2089283258.USD","LU2543165471.USD","IE00BZ9MQY76.HKD","LU0466842654.USD","LU1152091168.USD","LU2106854487.HKD","LU2471134523.USD","IE00BK4W5M84.HKD","CGDG","IE00BZ08YR35.GBP","XLK","LU0314109678.HKD","LU1066053197.SGD","LU1989771016.USD","IE0003U64NQ7.SGD","SG9999015978.USD","BK4579","LU2552382215.SGD","LU0823417737.USD","BK4512","LU2860962120.EUR","BK4612","LU2746668461.USD","LU1201861165.SGD","BK1515","LU1582987597.SGD","LU1069347547.HKD","LU2756315664.SGD","IE00BJTD4N35.SGD","BK4007","LU0501845795.SGD","LU0784385840.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU2065171311.SGD","IE00BLSP4452.SGD","AVGU","LU0097036916.USD","HK0000532082.HKD","XLP","BK4605","LU0225283273.USD","LU1814569148.SGD","LU2552382058.USD","LU0820562030.AUD","LU2237443978.SGD","SG9999015952.SGD","SG9999014559.SGD","AVL","LU2237438978.USD","LU2247934214.USD","IE00BKVL7J92.USD","LU2286300806.USD","LU2125154935.USD","IE00BMCWC346.EUR","LU1645745479.HKD","LU0345770993.USD","LU1988902786.USD","BK4141","LU0267386448.USD","APLY","LU0208291251.USD","HK0000819398.USD","LU1670711123.USD","IE000Q6AESB8.SGD","CIBR","LU0158827948.USD","FSTA","GB00BDT5M118.USD","LU0070217475.USD","LU2242649171.HKD","BK4561","LU0158827781.USD","LU1960683339.HKD","LU1430594728.SGD","IE000KEQY171.SGD","LU0784385170.HKD","LU1914381329.SGD","LU2462591277.SGD","BK4533","LU0353189680.USD","LU1868837136.USD","LU0096362180.USD","LU0130103400.USD","LU0823434583.USD","LU1989763427.SGD","LU1301847155.USD","LU1861214812.USD","LU2764263203.CNY","HK0000914660.USD","LU0314106906.USD","LU1917777945.USD","LU2100268510.USD","LU0642271901.SGD","LU2089284900.SGD","LU1791710582.SGD","LU1145028129.USD","LU1935043536.SGD","LU2355687059.USD","LU1267930490.SGD","SG9999002224.SGD","LU2602419157.SGD","LU1069344957.HKD","BK4551","BK4575","LU0345768740.USD","BK4568","LU0238689110.USD","LU2191332357.HKD","LU1008478684.HKD","LU2506951958.HKD","LU2244417387.USD","LU0154236417.USD","LU1366333091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649396798","title":"GSK, Sino Biopharmaceutical Unit Expand Collaboration to Cover Two GSK Respiratory Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2649396798","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649396798?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:15","pubTimestamp":1783505733,"startTime":"0","endTime":"0","summary":"GSK  agreed to expand its exclusive strategic collaboration with Sino Biopharmaceutical's Chia Tai Tianqing Pharmaceutical Group subsidiary to include rights to commercialize two GSK respiratory therapies in mainland China, Sino said in a Wednesday filing.Under the deal, Chia Tai Tianqing Pharmaceutical will secure the commercialization rights to GSK's Trelegy Ellipta and Anoro Ellipta in mainland China, according to the filing. Financial details were not disclosed.The Sino unit will work with GSK to ensure smooth product rollout in China, covering supply, commercialization and regulatory compliance, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4532","LU1829250122.USD","GSKH","GSK.UK","BK4588","BK4585","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649961643","title":"Barclays Remains a Sell on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649961643","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649961643?lang=en_us&edition=fundamental","pubTime":"2026-07-08 16:46","pubTimestamp":1783500369,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Sell rating on GlaxoSmithKline today and set a price target of £19.00. According to TipRanks, Gordon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-sell-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-sell-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","CFA","BK4532","BK4588","LU1829250122.USD","GSK.UK","GSKH","BK4007","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649637389","title":"Dow Jones Top Company Headlines at 3 am ET: Sino Biopharm Strikes Drug Licensing Deal with Astrazeneca, Deepens GSK Partnership | White ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2649637389","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649637389?lang=en_us&edition=fundamental","pubTime":"2026-07-08 15:00","pubTimestamp":1783494000,"startTime":"0","endTime":"0","summary":"Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK PartnershipSino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payment","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENFR","BK4532","GSK","USAI","UMI","BK4007","GSK.UK","AMZA","EMLP","BK4588","ET","BK4561","EIPX","AMLP","BK4581","TPZ","BK4590","MDST","BK4585","LU1829250122.USD","GSKH","BK4144","MLPA","EIPI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649616957","title":"Sino Biopharm Deepens GSK Respiratory Deal to Cement China Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2649616957","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649616957?lang=en_us&edition=fundamental","pubTime":"2026-07-08 12:07","pubTimestamp":1783483636,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical ( ($HK:1177) ) just unveiled an announcement. Sino Biopharmaceutical is a leading Chinese pharmaceutical group with a strong...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-deepens-gsk-respiratory-deal-to-cement-china-lead?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-deepens-gsk-respiratory-deal-to-cement-china-lead?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBB","BK4588","LU1829250122.USD","BK4585","GSKH","BK4532","GSK","GSK.UK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649931584","title":"GSK’s StrateGIST Frontline Trial Puts New Cancer Drug Velzatinib in the Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2649931584","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649931584?lang=en_us&edition=fundamental","pubTime":"2026-07-08 00:30","pubTimestamp":1783441817,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is launching a Phase 3 study called StrateGIST Frontlin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-strategist-frontline-trial-puts-new-cancer-drug-velzatinib-in-the-spotlight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-strategist-frontline-trial-puts-new-cancer-drug-velzatinib-in-the-spotlight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4532","BK4588","LU1829250122.USD","GSK.UK","GSKH","BK4007","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173871150","title":"HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=1173871150","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173871150?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:12","pubTimestamp":1783422743,"startTime":"0","endTime":"0","summary":"HANXBIO-B has announced a strategic partnership aimed at harnessing the power of artificial intelligence to revolutionize the drug development process.The company has entered into a formal agreement...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","GDOC","BK1535","WRND","AGIX","PBE","BK4585","BK1173","IBB","QTOC","ARTY","SBIO","AIPO","BK1161","VTHR","BBP","03378","LFSC","BK4588","CHAT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}